Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Catch 22

RE: Catch 22

posted on Jun 13, 2006 05:04AM
Ease, I respectifully disagree with waiting for repurchase. While I like the idea of a buy back; 10% is not going to reduce the market cap to such were we are lean and mean.

Right now, I rather take revenue announcements. Steady licensing agreements over the next 12 months. This will build the SP up.

regards

Share
New Message
Please login to post a reply